A publication from 2023 researching Fabry disease, pharm-analyt involved
Comparison of efficacy between subcutaneous and intravenous application of moss-aGal in the mouse model of Fabry disease, co-author Daniel Mascher, Gb3 and lyso Gb-3
Download PDF